婴幼儿血管瘤治疗决策及疗效评价的研究

Study on Treatment Decision and Efficacy Evaluation of Infantile Hemangiomas

目的探究婴幼儿血管瘤治疗决策及疗效。方法选取2011年1月—2021年12月广东省江门市中心医院收治的110例婴幼儿血管瘤患儿为研究对象,随机数表法将其分为观察组、对照组,每组55例。对照组采用常规疗法,观察组采用普萘洛尔治疗,比较两组患儿的治疗效果、不良反应和临床指标。结果观察组治疗效果优于对照组,差异有统计学意义(P<0.05)。观察组不良反应率为3.64%,低于对照组的14.55%,差异有统计学意义(χ^(2)=3.960,P<0.05)。结论婴幼儿血管瘤应用普萘洛尔治疗效果更好,用药安全性更高,患儿的临床指标改善幅度更大。

Objective To investigate the treatment decision and efficacy of infantile hemangioma.Methods From January 2011 to December 2021,110 children of infantile hemangiomas admitted to Jiangmen Central Hospital were randomly selected as the study objects,and the children were divided into the observation group and the control group by the method of random number table,with 55 children in each group.The control group was treated with conventional therapy and the observation group was treated with propranolol,and the treatment effects,adverse reactions and clinical indicators of the two groups were compared.Results The therapeutic effect of the observation group was better than that of the control group,and the difference was statistically significant(P<0.05).The rate of adverse reactions in the observation group was 3.64%,which was lower than 14.55%in the control group,the difference was statistically significant(χ^(2)=3.960,P<0.05).Conclusion The application of propranolol for infantile hemangioma has better therapeutic effect,the safety of the drug is higher,and the clinical indexes of the children are more improved.